Artesian VC

EMOTAI is a privately held company based in Lisbon, Portugal, founded in 2018. It specializes in the development of a wearable headband that monitors brain waves and heart rate, particularly targeting gamers. The company offers a biosignal tracking and training platform that provides performance reports, detailing metrics such as focus, stress, engagement, and heart rate levels. By analyzing these biosignals, EMOTAI aims to enhance human performance and wellness, helping users improve their focus and working memory, ultimately enabling them to perform better in gaming and other activities.

NUROCHEK is an Australian innovation and a world-first brain activity assessment device. www.nurochek.com is a portable headset using clinically validated, patented technology to actually measure the brain’s electrical activity and send results to a smartphone for analysis and the cloud for storage and future comparison. In 2 minutes NUROCHEK tells us when a player has abnormal brain activity, and when has returned to normal and their doctor can assess they are safe to return to playing. The current standards, such as the SCAT Test is a mixture of assessments, and takes an experienced doctor over 20 minutes. Our revolutionary technology is designed to take the uncertainty, and controversy, out of concussion diagnosis. Whilst critical for elite sports, it’s also for school and community sports. Research shows that the brain’s electrical activity (or EEG) actually changes in concussion, and returns to the pre-concussion baseline alongside clinical recovery. Globally there are 10 million concussions every year, 5 million of these in children and adolescents. The headset will retail for under $500 and the software sell for <$30/user/year. At the elite level of major sports, NUROCHEK will become a vital part of the Head Injury Assessment, in helping team medial staff decide if a player needs to leave the field or can return to the same game. During recovery, and prior to playing again, NUROCHEK will help medical staff analyse that the player is back to pre-injury (“baseline”) brain activity, and can therefore return to sport. Players can be tested after injury and in return to play scenarios, or weekly as a “fit for play” test: not all concussions are witnessed and recognized, and whether they occur at training, in a game, off-field at home or in the school playground, or if multiple smaller (sub-concussive) impacts cause a change in brain function, NUROCHEK will show the change